Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment.
A 37,000-dalton polypeptide (p37K) present on purified extracellular vaccinia virus but absent from intracellular virus particles of classical morphology (G. Hiller et al., J. Virol. 39:903-913, 1981; L. G. Payne, J. Virol. 27:28-37, 1978) was further characterized. The polypeptide was only expressed in infected cells after onset of viral DNA replication. Phase partition experiments showed that it is relatively hydrophobic. Although p37K apparently is not a glycoprotein, in vivo radioisotope labeling detected tightly associated palmitic acid. Antibodies to p37K were used to monitor its distribution within infected cells at the light and electron microscopic levels. After synthesis p37K first accumulated in the Golgi region due to a tight membrane association. During progressing infection p37K-carrying membranes were used to form double-walled envelopes around brick-shaped vaccinia particles. Within these specialized vesicles vaccinia particles were moved through the cytoplasm toward the cell's surface, presumably along cellular routes for certain secretory products. Finally, single enveloped viruses were released into the extracellular space by an exocytotic process.
D000596:Amino Acids / Q000032:analysis; D006056:Golgi Apparatus / Q000378:metabolism*; D008854:Microscopy, Electron; D008856:Microscopy, Fluorescence; D008970:Molecular Weight; D019308:Palmitic Acid; D010169:Palmitic Acids / Q000032:analysis; D014616:Vaccinia virus / Q000648:ultrastructure*; D014764:Viral Proteins / Q000302:isolation & purification*; D014779:Virus Replication
D000596:Amino Acids; D010169:Palmitic Acids; D014764:Viral Proteins; D019308:Palmitic Acid